BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Eshraghian A. Current and emerging pharmacological therapy for non-alcoholic fatty liver disease. World J Gastroenterol 2017; 23(42): 7495-7504 [PMID: 29204050 DOI: 10.3748/wjg.v23.i42.7495]
URL: https://www.wjgnet.com/1007-9327/full/v23/i42/7495.htm
Number Citing Articles
1
Graziella Rodrigues, Andrea Janz Moreira, Silvia Bona, Elizângela Schemitt, Cláudio Augusto Marroni, Fábio Cangeri Di Naso, Alexandre Simões Dias, Thienne Rocha Pires, Jaqueline Nascimento Picada, Norma Possa Marroni. Simvastatin Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in Nonalcoholic Steatohepatitis Experimental ModelOxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/3201873
2
Ahad Eshraghian, Shahrokh Iravani, Pedram Azimzadeh. The Association between Angiotensin II Type 1 Receptor Gene A1166C Polymorphism and Non-alcoholic Fatty Liver Disease and Its SeverityMiddle East Journal of Digestive Diseases 2018; 10(2): 96 doi: 10.15171/mejdd.2018.97
3
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. Consenso mexicano de la enfermedad por hígado graso no alcohólicoRevista de Gastroenterología de México 2019; 84(1): 69 doi: 10.1016/j.rgmx.2018.11.007
4
Cynthia Barrera, Rodrigo Valenzuela, Miguel A. Rincón, Alejandra Espinosa, Sandra López-Arana, Daniel González-Mañan, Nalda Romero, Romina Vargas, Luis A. Videla. Iron-induced derangement in hepatic Δ-5 and Δ-6 desaturation capacity and fatty acid profile leading to steatosis: Impact on extrahepatic tissues and prevention by antioxidant-rich extra virgin olive oilProstaglandins, Leukotrienes and Essential Fatty Acids 2020; 153: 102058 doi: 10.1016/j.plefa.2020.102058
5
Ahad Eshraghian, Saman Nikeghbalian, Kourosh Kazemi, Alireza Shamsaeefar, Bita Geramizadeh, Seyed Ali Malek-Hosseini. Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosisHPB 2020; 22(4): 521 doi: 10.1016/j.hpb.2019.07.015
6
Fabiola López-Bautista, Varenka J. Barbero-Becerra, María Yolanda Ríos, M. Ángeles Ramírez-Cisneros, Cristell A. Sánchez-Pérez, Martha H. Ramos-Ostos, Misael Uribe, Norberto C. Chávez-Tapia, Eva Juárez-Hernández. Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patientsAnnals of Hepatology 2020; 19(5): 482 doi: 10.1016/j.aohep.2020.06.008
7
Oren Tirosh. Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease ProgressionOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/2548154
8
Kamyar Asadipooya, Kamran B. Lankarani, Rishi Raj, Mohammadreza Kalantarhormozi. RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver DiseaseInternational Journal of Endocrinology 2019; 2019: 1 doi: 10.1155/2019/2151302
9
Melinda H. Spooner, Donald B. Jump. Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and childrenCurrent Opinion in Clinical Nutrition & Metabolic Care 2019; 22(2): 103 doi: 10.1097/MCO.0000000000000539
10
Andrea Morán-Costoya, Ana M. Proenza, Magdalena Gianotti, Isabel Lladó, Adamo Valle. Sex Differences in Nonalcoholic Fatty Liver Disease: Estrogen Influence on the Liver–Adipose Tissue CrosstalkAntioxidants & Redox Signaling 2021; 35(9): 753 doi: 10.1089/ars.2021.0044
11
Ruifang Zhao, Meilin Zhu, Shuang Zhou, Weiyue Feng, Hanqing Chen. Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver DiseaseFrontiers in Chemistry 2020; 8 doi: 10.3389/fchem.2020.00407
12
Madlen Matz-Soja. The Molecular Nutrition of Fats2019; : 201 doi: 10.1016/B978-0-12-811297-7.00015-9
13
Jiang-Hua Zhou, Jing-Jing Cai, Zhi-Gang She, Hong-Liang Li. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practiceWorld Journal of Gastroenterology 2019; 25(11): 1307-1326 doi: 10.3748/wjg.v25.i11.1307
14
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical ChallengesDigestive Diseases and Sciences 2019; 64(12): 3413 doi: 10.1007/s10620-019-05716-1
15
Jing-ping Zhou, Yan-dan Ren, Qin-yu Xu, Yang Song, Fei Zhou, Mei-Ya Chen, Jing-jing Liu, Li-Gang Chen, Jin-Shui Pan. Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/4087928
16
Juan Li, Lv Zhu, Yu-mei Zhang, Huan Chen, Yi-fan Miao, Hong-xin Kang, Hong-yu Ren, Mei-hua Wan, Dan Long, Wen-fu Tang. Sheng-Jiang Powder Ameliorates High Fat Diet Induced Nonalcoholic Fatty Liver Disease via Inhibiting Activation of Akt/mTOR/S6 Pathway in RatsEvidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/6190254
17
Xue-Yuan Jin, Chuan-Bao Zhu, Shi-Yong Fan, Jia-Lin Sun, Yu-Cong Shi, Chu-Han Wang, Hui-Fen Wang, Bo-Hua Zhong, Yi-Shan Yao, Wei-Guo Shi. Novel hypolipidemic conjugates of fatty acid and bile acid with lysine for linkageDrug Development and Industrial Pharmacy 2019; 45(6): 995 doi: 10.1080/03639045.2019.1590393
18
Ahad Eshraghian, Saman Nikeghbalian, Bita Geramizadeh, Kourosh Kazemi, Alireza Shamsaeefar, Seyed Ali Malek-Hosseini. Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: The impact of uric acidClinics and Research in Hepatology and Gastroenterology 2020; 44(4): 572 doi: 10.1016/j.clinre.2019.09.002
19
Adriana Sánchez-García, Amirhossein Sahebkar, Mario Simental-Mendía, Luis E. Simental-Mendía. Effect of ursodeoxycholic acid on glycemic markers: A systematic review and meta-analysis of clinical trialsPharmacological Research 2018; 135: 144 doi: 10.1016/j.phrs.2018.08.008
20
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. The Mexican consensus on nonalcoholic fatty liver diseaseRevista de Gastroenterología de México (English Edition) 2019; 84(1): 69 doi: 10.1016/j.rgmxen.2019.02.003
21
Xuan G. Luong, Sarah K. Stevens, Andreas Jekle, Tse-I Lin, Kusum Gupta, Dinah Misner, Sushmita Chanda, Sucheta Mukherjee, Caroline Williams, Antitsa Stoycheva, Lawrence M. Blatt, Leonid N. Beigelman, Julian A. Symons, Pierre Raboisson, David McGowan, Koen Vandyck, Jerome Deval, Olivier Barbier. Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)PLOS ONE 2020; 15(12): e0240338 doi: 10.1371/journal.pone.0240338
22
Dominic S. Ng. Emerging insight into the role of cellular cholesterol in the pathogenesis of nonalcoholic steatohepatitis progressionCurrent Opinion in Lipidology 2020; 31(4): 262 doi: 10.1097/MOL.0000000000000693
23
Sreeshma Tellapuri, Patrick D. Sutphin, Muhammad S. Beg, Amit G. Singal, Sanjeeva P. Kalva. Staging systems of hepatocellular carcinoma: A reviewIndian Journal of Gastroenterology 2018; 37(6): 481 doi: 10.1007/s12664-018-0915-0
24
Ming Li, Qian Wang, Yong Li, Shengtian Cao, Yingjun Zhang, Zhongqing Wang, Guozhu Liu, Jing Li, Baohua Gu. Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challengesPharmacology & Therapeutics 2020; 212: 107539 doi: 10.1016/j.pharmthera.2020.107539
25
April D. Lake, Rhiannon N. Hardwick, Christopher P. Leamon, Philip S. Low, Nathan J. Cherrington. Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitisToxicology and Applied Pharmacology 2019; 368: 49 doi: 10.1016/j.taap.2019.02.009
26
Gehan H. Heeba, Reham M. El-Deen, Rania G. Abdel-latif, Mohamed M.A. Khalifa. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative studyCanadian Journal of Physiology and Pharmacology 2020; 98(8): 498 doi: 10.1139/cjpp-2019-0487
27
Hiromi Chikada, Kinuyo Ida, Yuji Nishikawa, Yutaka Inagaki, Akihide Kamiya. Liver-specific knockout of B cell lymphoma 6 suppresses progression of non-alcoholic steatohepatitis in miceScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66539-z
28
Yeonhwa Song, Sanghwa Kim, Jinyeong Heo, David Shum, Su-Yeon Lee, Minji Lee, A-Ram Kim, Haeng Ran Seo. Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids modelScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-90263-x
29
Minhua Lin, Huamin Zeng, Guiqing Deng, Jiapei Lei, Jinxin Li. Vitamin E in paediatric non-alcoholic fatty liver disease: a meta-analysisClinics and Research in Hepatology and Gastroenterology 2021; 45(3): 101530 doi: 10.1016/j.clinre.2020.08.008
30
Milica Culafic, Sandra Vezmar Kovacevic, Violeta Dopsaj, Branislav Oluic, Nemanja Bidzic, Branislava Miljkovic, Djordje Culafic. Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitisJournal of Medical Biochemistry 2019; 0(0) doi: 10.2478/jomb-2019-0043
31
Gen-shen Cai, Hui Su, Jing Zhang. Protective effect of probiotics in patients with non-alcoholic fatty liver diseaseMedicine 2020; 99(32): e21464 doi: 10.1097/MD.0000000000021464
32
Eun-Yong Choi, Jin Ouk Choi, Chan Young Park, Seon-Hee Kim, Donghyun Kim. Water Extract of Artemisia annua L. Exhibits Hepatoprotective Effects Through Improvement of Lipid Accumulation and Oxidative Stress-Induced CytotoxicityJournal of Medicinal Food 2020; 23(12): 1312 doi: 10.1089/jmf.2020.4696